Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Retinoblastoma × Observation × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 12 Stomach Neoplasms 11 Prostatic Neoplasms 10 Neoplasms 10 Endometrial Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasm Metastasis 6 Oropharyngeal Neoplasms 5 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Sarcoma 4 Recurrence 4 Rectal Neoplasms 4 Esophageal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Gastrointestinal Stromal Tumors 3 Gallbladder Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Venous Thromboembolism 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2

Interventions

Carboplatin 18 Etoposide 15 Vincristine 13 Melphalan 10 Filgrastim 10 Topotecan 8 Granulocyte Colony-Stimulating Factor 8 Cyclophosphamide 8 Thiotepa 6 Cryotherapy 5 Mesna 4 Peripheral Blood Stem Cell Transplantation 3 Drug Therapy 3 Doxorubicin 3 Busulfan 3 Temozolomide 2 Radiotherapy 2 Magnetic Resonance Imaging 2 Ifosfamide 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1 etoposide phosphate 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡